Authors
Loading...
Indirect analysis reveals no significant difference in progression-free survival among CLL treatment methods, implying flexible selection based on patient factors.
Molica et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: